Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Christie M. Ballantyne"'
Publikováno v:
Journal of Clinical Lipidology. 17:297-302
Publikováno v:
Journal of Clinical Lipidology. 17:64-67
A 20-year-old male presented with severe elevation in low-density lipoprotein cholesterol (LDL-C). Initial genetic testing for familial hypercholesterolemia was negative. Patient also had low albumin, and further genetic testing showed homozygous var
Autor:
Ewa Karwatowska-Prokopczuk, Jean-Claude Tardif, Daniel Gaudet, Christie M. Ballantyne, Michael D. Shapiro, Patrick M. Moriarty, Seth J. Baum, Eric St Amour, Veronica J. Alexander, Shuting Xia, James D. Otvos, Joseph L. Witztum, Sotirios Tsimikas
Publikováno v:
Journal of Clinical Lipidology. 16:617-625
Olezarsen is a hepatocyte-targeted, GalNAc-modified antisense oligonucleotide that decreases plasma levels of apolipoprotein C-III (apoC-III) and triglyceride-rich lipoproteins (TRLs).To define the effect of olezarsen on NMR-derived lipoprotein parti
Publikováno v:
Journal of Clinical Lipidology. 15:649-652
Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor that reduces levels of low-density lipoprotein-cholesterol (LDL-C) in the plasma by inhibition of cholesterol synthesis in hepatic cells, which leads to up-regulation of hepati
Autor:
Ruth Frikke-Schmidt, Christie M. Ballantyne, Seth S. Martin, Peter W.F. Wilson, Alan T. Remaley, Terry A. Jacobson, Elizabeth A. Jackson, Michael H. Davidson, N-Anh Le, Hubert W. Vesper
Publikováno v:
Journal of Clinical Lipidology. 15:629-648
Lipoprotein measurements are pivotal in the management of patients at risk for atherosclerotic coronary heart disease (CHD) with myocardial infarction and coronary death as the main outcomes, and for atherosclerotic cardiovascular disease (ASCVD), wh
Publikováno v:
Journal of Clinical Lipidology. 15:530-537
Clinical lipidology belongs par excellence to the preventive mode of medical practice. This Roundtable brings two long-time advocates of cardiometabolic prevention and a newly minted preventive cardiologist into a discussion that expands their recent
Autor:
Christie M. Ballantyne, Elizabeth Selvin, Chiadi E Ndumele, Beatriz D'Agord Schaan, Mariana Lazo, Natalie Daya, Mariana Sbaraini da Silva, Olive Tang
Publikováno v:
Obesity (Silver Spring)
Objective The aim of this study was to study the prospective association between N-terminal pro-brain natriuretic peptide (NT-proBNP) and changes in weight and obesity risk in a community-based population. Methods Data from 9,681 participants from th
Autor:
Anandita Agarwala, Elena Deych, Laney K. Jones, Amy C. Sturm, Karen Aspry, Zahid Ahmad, Christie M. Ballantyne, Anne C. Goldberg
Publikováno v:
Journal of clinical lipidology.
Familial hypercholesterolemia (FH) is associated with an increased prevalence of premature atherosclerotic cardiovascular disease (ASCVD), however, little is known about sex-specific differences in premature ASCVD and its risk factors.The present stu
Autor:
Magnus O. Wijkman, Brian L. Claggett, Marcus V.B. Malachias, Muthiah Vaduganathan, Christie M. Ballantyne, Dalane W. Kitzman, Thomas Mosley, Kunihiro Matsushita, Scott D. Solomon, Marc A. Pfeffer
Publikováno v:
Diabetes research and clinical practice. 194
In this community-based cohort of 5861 individuals followed for median 7.2 years, the discriminatory ability of NT-proBNP alone in predicting mortality was similar to that of multiple conventional markers of risk in people without diabetes. In people
Publikováno v:
Journal of Clinical Lipidology. 15:245-247